Cargando…

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection

In late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus emerged in China and quickly spread into a worldwide pandemic. It has caused millions of hospitalizations and deaths, despite the use of COVID-19 vaccines. Convalescent plasma and monoclonal antibodies emerged as maj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jha, Aruni, Barker, Douglas, Lew, Jocelyne, Manoharan, Vinoth, van Kessel, Jill, Haupt, Robert, Toth, Derek, Frieman, Matthew, Falzarano, Darryl, Kodihalli, Shantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549041/ https://www.ncbi.nlm.nih.gov/pubmed/36216961 http://dx.doi.org/10.1038/s41598-022-21223-2

Ejemplares similares

Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice
por: Jha, Aruni, et al.
Publicado: (2022)

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
por: Facciuolo, Antonio, et al.
Publicado: (2023)

Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule
por: Kammanadiminti, Srinivas, et al.
Publicado: (2023)

Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice
por: Barker, Douglas, et al.
Publicado: (2023)

Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019)

Interferon Regulatory Factor 3-Mediated Signaling Limits Middle-East Respiratory Syndrome (MERS) Coronavirus Propagation in Cells from an Insectivorous Bat
por: Banerjee, Arinjay, et al.
Publicado: (2019)

SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model
por: Di, Yunyun, et al.
Publicado: (2022)

High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection
por: Facciuolo, Antonio, et al.
Publicado: (2022)

Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology
por: Khan, Juveriya Qamar, et al.
Publicado: (2023)

Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study
por: Liu, Sean T. H., et al.
Publicado: (2023)

Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus
por: Banerjee, Arinjay, et al.
Publicado: (2020)

Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019)

Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
por: Beliveau, Martin, et al.
Publicado: (2022)

Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
por: Nguyen, Hai Trong, et al.
Publicado: (2021)

Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets
por: Francis, Magen E., et al.
Publicado: (2021)

Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model
por: Sroga, Patrycja, et al.
Publicado: (2021)

Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets
por: Francis, Magen E., et al.
Publicado: (2021)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
por: Ostrov, David A., et al.
Publicado: (2021)

Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2
por: Francis, Magen E., et al.
Publicado: (2023)

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
por: Weston, Stuart, et al.
Publicado: (2020)

Combination Therapy with Antibiotics and Anthrax Immune Globulin Intravenous (AIGIV) Is Potentially More Effective than Antibiotics Alone in Rabbit Model of Inhalational Anthrax
por: Kammanadiminti, Srinivas, et al.
Publicado: (2014)

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
por: Banerjee, Arinjay, et al.
Publicado: (2022)

SARS and MERS: recent insights into emerging coronaviruses
por: de Wit, Emmie, et al.
Publicado: (2016)

High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
por: Li, Wei, et al.
Publicado: (2020)

Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017)

The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health
por: Sheahan, Timothy P, et al.
Publicado: (2020)

Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen
por: Grishin, Andrey M., et al.
Publicado: (2022)

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
por: Li, Wei, et al.
Publicado: (2020)

Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells
por: Icho, Simoun, et al.
Publicado: (2022)

The Importance of Animal Models in the Development of Vaccines
por: Kiros, Tadele G., et al.
Publicado: (2012)

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
por: Schuhenn, Jonas, et al.
Publicado: (2022)

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)

Effect of educational intervention on the knowledge of rabies among medical school students of Chennai
por: Manoharan, Aravind, et al.
Publicado: (2019)

Growth and Quantification of MERS‐CoV Infection
por: Coleman, Christopher M., et al.
Publicado: (2015)

Treating MERS-CoV during an outbreak
por: Coleman, Christopher M, et al.
Publicado: (2014)

Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells
por: Zhang, Yamei, et al.
Publicado: (2022)

Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load
por: Swan, Cynthia L., et al.
Publicado: (2023)

The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2
por: Lopez-Orozco, Joaquin, et al.
Publicado: (2023)

PREVALENCE OF SCHIZOPHRENIA IN AN URBAN COMMUNITY IN MADRAS
por: Padmavathi, R., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_2dtksb86ap64mug5e7t82o68qv